Active ingredientEthambutol diHClCat. No. P-E114-001CAS 1070-11-7Family · Pharmaceutical analytical standards
Ethambutol
An antituberculosis drug discovered in 1961 that hinders the building of the mycobacterial cell wall by blocking the enzyme arabinosyl transferase; it is used with isoniazid, rifampicin and pyrazinamide and is on the WHO List of Essential Medicines. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and nitrosamines.
Did you know?It is a classic example of an 'old' drug introduced as a single enantiomer from the start: the (S,S) form is 500 times more potent than its (R,R) mirror image and 12 times more than the meso form.
Go to the active ingredient →Active ingredientEthambutol diHClCat. No. P-E114-001CAS 1070-11-7
Pharmacopoeial impurityEthambutol EP Impurity BCat. No. P-E114-002
Pharmacopoeial impurityEthambutol EP Impurity B DihydrochlorideCat. No. P-E114-003CAS 32454-69-6
Pharmacopoeial impurityEthambutol EP Impurity CCat. No. P-E114-004CAS 134566-79-3
Isotopically labelled(R,R)-Ethambutol-d4 DiHClCat. No. P-E114-005
Isotopically labelledEthambutol-d4Cat. No. P-E114-006CAS 1129526-19-7
Isotopically labelledEthambutol-d8Cat. No. P-E114-007CAS 1129526-23-3
NitrosamineN,N-Dinitroso EthambutolCat. No. P-E114-008CAS 2792161-95-4
NitrosamineN-Nitroso EthambutolCat. No. P-E114-009No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceEthambutol hydrochloride CRSEDQM code E1850000Family EthambutolNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.